Product Information
BRIVIACT 10 MG TABLET is a brand product labeled by UCB, Inc., priced at $23.9864 per EA under NDC 50474037066. Its NADAC has been published 118 times since May 22, 2024.
FDA first approved this application on May 12, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
UCB, Inc.NDC
50474037066
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BRIVARACETAMApproval Type
New Drug (NDA)
FDA Application
NDA205836FDA Approved
5/12/2016
TE Code
AB
On Market Since
5/12/2016
Pharmacological Classes
Price Statistics
The NADAC for BRIVIACT 10 MG TABLET has been published 118 times since May 22, 2024, and over the history we have for it it has risen 4.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.9864 per EA |
|---|---|
| All-time high | $23.9864 (Aug 19, 2026) |
| All-time low | $22.9334 (Dec 18, 2024) |
| 52-week high | $23.9864 |
| 52-week low | $23.3674 |
| Median price | $23.4494 |
| Average price | $23.4572 |
| Largest weekly change | +2.6% (Jan 14, 2026) |
| Weeks tracked | 118 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the brivaracetam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BRIVIACT 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BRIVIACT 10 MG TABLET, manufactured by UCB, Inc., is $23.9864 per EA (NDC 50474037066), effective Aug 19, 2026.
How has the price of BRIVIACT 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for BRIVIACT 10 MG TABLET has risen 4.3%. It has been tracked across 118 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for BRIVIACT 10 MG TABLET?
Since May 22, 2024, the NADAC for BRIVIACT 10 MG TABLET has ranged from a low of $22.9334 (Dec 18, 2024) to a high of $23.9864 (Aug 19, 2026), with a median of $23.4494 per EA.
Are there cheaper alternatives to BRIVIACT 10 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BRIVIACT 10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BRIVIACT 10 MG TABLET?
BRIVIACT 10 MG TABLET (NDC 50474037066) is labeled by UCB, Inc., and CMS classifies it as a brand product.